Syringe Aldehyde Detection via Derivatization and HPLC

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for reducing aldehyde release from syringe adhesives are non-specific and unstable, particularly ineffective at low concentrations, and can damage syringe components, while existing detection methods are not precise or sensitive enough to determine aldehydes independently of the drug type or syringe contents.

Innovation Solution

A method involving treating syringes at elevated temperatures (≥50°C) and using a derivatization treatment with a phenyl-substituted compound like 2,4-dinitrophenyl hydrazine followed by reverse phase HPLC coupled to a UV detector for analysis, to extract and detect residual aldehydes effectively.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If autoclave treatment is used for sterilization, then sterilization is achieved, but the gluing seal is weakened and rubber components are damaged

Engineering Contradiction:
ImprovesterilizationVSAvoidgluing seal
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent changes the sterilization parameters from autoclave (high temperature steam) to EtO gas sterilization (lower temperature, chemical gas), which achieves sterilization while preserving the integrity of the gluing seal and rubber components. This parameter change resolves the contradiction between achieving sterilization and maintaining component strength.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If conventional derivatization agents like PFBHA are used, then detection is possible, but sensitivity is insufficient for very low aldehyde concentrations

Engineering Contradiction:
Improvealdehyde detectionVSAvoiddetectable aldehyde amount
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent changes the chemical parameters of the derivatization agent from PFBHA to 2,4-DNPH, which has superior reactivity with aldehydes and produces highly detectable hydrazone derivatives. This chemical substitution enables detection at very low concentrations (ng/mL levels), resolving the contradiction between detection capability and sensitivity for trace amounts.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If UV curing parameters are varied, then adhesive curing is achieved, but aldehyde reduction is not specific or stable

Engineering Contradiction:
Improveadhesive curingVSAvoidaldehyde reduction
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent extracts and addresses the aldehyde issue separately from the adhesive curing process. Instead of trying to control aldehyde levels through UV curing parameter optimization, the patent uses post-curing extraction treatments (solvent extraction, heat extraction) to remove aldehydes after the adhesive has cured. This separates the curing function from the aldehyde reduction function, achieving both reliably.

Inventive Principle:
Principle #2Taking out (Extraction)

4Measurement precision

If liquid chromatography is used for detection, then aldehyde determination is possible, but results depend on multiple factors including derivatization substance

Engineering Contradiction:
Improvealdehyde determinationVSAvoiddetection method
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent changes the detection parameters by selecting 2,4-DNPH as the derivatization agent, which provides consistent, high-yield reactions with aldehydes that are well-suited for reverse phase HPLC separation and UV detection. This standardized chemical approach reduces variability from derivatization efficiency and improves method robustness, resolving the contradiction between detection precision and method complexity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces aldehyde release to low levels (<60 ng/syringe for formaldehyde, <300 ng/syringe for acetaldehyde, and <20 ng/syringe for acrolein) and provides a precise, sensitive, and stable analytical method for detecting aldehydes, making syringes suitable for use with protein-based drugs.

Implementation Method 1

a derivatization treatment of the sample with a compound of formula Ar‑NH‑NH 2 , in which Ar is a phenyl substituted by one or more electron‑withdrawing groups

Methodology Applied
Scientific EffectDerivatization reaction: Chemical Bonding

Implementation Method 2

Analysis of the solution resulting from step ii) by reverse phase HPLC coupled to UV detector

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 3

reverse phase HPLC coupled to UV detector

Methodology Applied
Scientific EffectAbsorption spectroscopy: Absorption Spectroscopy

Data Source

PatentEP4067896B1Method for determining residual aldehydes releasable from a syringe
Publication Date: 2024.12.25 NUOVA OMPI SRL
  • EP4067896B1 patent drawingFigure 1~2A
  • EP4067896B1 patent drawingFigure 2B~2C
  • EP4067896B1 patent drawing

AI summary

The present invention relates to a method for extracting aldehydes from the adhesive used for gluing needles to syringes, and to a method for determining the aldehydes releasable from said syringes, before or after such a treatment. In particular, the present invention relates to a analytical method for detecting residual aldehydes releasable from a syringe (1), wherein said syringe is a syringe (1)-needle (3) assembly, wherein the needle (3) is coupled to the cone (2) of the syringe (1) by means of an adhesive or glue (4) containing residual aldehydes, the method comprising the following steps: iii) preparation of the sample to be analysed by isolating the cone (2) of the syringe (1) comprising the needle portion (3) inserted in it and the glue (4) ; iv) derivatization treatment of the sample of step i) with a compound of formula Ar-NH-NH2, wherein Ar is a phenyl substituted with one or more electron-attractant groups; iii) analysis of the solution resulting from step ii) by reverse-phase HPLC coupled to UV detector.